These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21876012)

  • 1. Company profits from side effects of glaucoma treatment.
    Banaszek A
    CMAJ; 2011 Oct; 183(14):E1058. PubMed ID: 21876012
    [No Abstract]   [Full Text] [Related]  

  • 2. Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):43-4. PubMed ID: 19478690
    [No Abstract]   [Full Text] [Related]  

  • 3. Latisse: empirical discovery yields treatment for sparse eyelashes.
    Woodson SA
    Nurs Womens Health; 2009 Jun; 13(3):243-8. PubMed ID: 19523139
    [No Abstract]   [Full Text] [Related]  

  • 4. Latisse (bimatoprost) for enhancement of eyelashes.
    Flaharty PM; Flaharty KK; Gorman L
    Insight; 2014; 39(3):24-6. PubMed ID: 25195339
    [No Abstract]   [Full Text] [Related]  

  • 5. My eyelashes have become very thin over the years, and I'm hopeless with mascara. Is it safe to use this new prescription product that's supposed to grow eyelashes?
    Mayo Clin Health Lett; 2009 Dec; 27(12):8. PubMed ID: 20082494
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 Sep; 36(9):1361-71. PubMed ID: 20384750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iris heterochromia and unilateral eyelash hypertrichosis.
    Rao RC; Ballard TN; Chen TC
    JAMA; 2015 May; 313(19):1967-8. PubMed ID: 25988467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimatoprost - a review.
    Patil AJ; Vajaranant TS; Edward DP
    Expert Opin Pharmacother; 2009 Nov; 10(16):2759-68. PubMed ID: 19874254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.
    Aydin S; Işikligil I; Tekşen YA; Kir E
    Cutan Ocul Toxicol; 2010 Sep; 29(3):212-6. PubMed ID: 20670089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension.
    Robin AL
    Eur J Ophthalmol; 2007; 17(4):685-6; author reply 686-7. PubMed ID: 17671954
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
    Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
    Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bimatoprost therapy in glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2009; 53(3):34-45. PubMed ID: 19899545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension.
    Ling Z; Zhang M; Hu Y; Yin Z; Xing Y; Fang A; Ye J; Chen X; Liu D; Wang Y; Sun W; Dong Y; Sun X
    Chin Med J (Engl); 2014; 127(5):905-10. PubMed ID: 24571886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
    Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):67-71. PubMed ID: 21214361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].
    Skorkovská K
    Cesk Slov Oftalmol; 2008 Jul; 64(4):144-8. PubMed ID: 18780653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-week study evaluating the efficacy of bimatoprost 0.03% in patients with pseudoexfoliative and open-angle glaucoma.
    Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Toto L; Mastropasqua L
    Eur J Ophthalmol; 2009; 19(4):594-600. PubMed ID: 19551674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
    Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of prostaglandin analogues on the anterior chamber depth of patients with primary open-angle glaucoma.
    Simşek S; Yülek F; Cakmak HB; Midillioğlu IK
    Cutan Ocul Toxicol; 2009; 28(3):125-8. PubMed ID: 19653869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of topical bimatoprost.
    Mikelberg FS
    Can J Ophthalmol; 2009 Apr; 44(2):209; author reply 209. PubMed ID: 19491959
    [No Abstract]   [Full Text] [Related]  

  • 20. Lower eyelid melanoma during bimatoprost (Lumigan) therapy.
    Sun LL; Welch RT; Vu P
    Clin Exp Ophthalmol; 2012 Mar; 40(2):213-4. PubMed ID: 22004163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.